{"id":"https://openalex.org/W3095468898","doi":"https://doi.org/10.1182/blood-2020-141540","title":"Combinatorial Antigen Targeting Strategy for Acute Myeloid Leukemia","display_name":"Combinatorial Antigen Targeting Strategy for Acute Myeloid Leukemia","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095468898","doi":"https://doi.org/10.1182/blood-2020-141540","mag":"3095468898"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-141540","doi":"https://doi.org/10.1182/blood-2020-141540","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141540","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057599279","display_name":"P\u0131nar Ataca Atilla","orcid":"https://orcid.org/0000-0001-9462-4241","observed_orcids":["https://orcid.org/0000-0001-9462-4241"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pinar Ataca Atilla","raw_affiliation_strings":["Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046750921","display_name":"Mary Kathryn McKenna","orcid":"https://orcid.org/0000-0002-2357-1733","observed_orcids":["https://orcid.org/0000-0002-2357-1733"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary K McKenna","raw_affiliation_strings":["Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086415382","display_name":"Norihiro Watanabe","orcid":"https://orcid.org/0000-0002-7678-0141","observed_orcids":["https://orcid.org/0000-0002-7678-0141"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norihiro Watanabe","raw_affiliation_strings":["Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084741818","display_name":"Maksim Mamonkin","orcid":"https://orcid.org/0000-0001-7178-8163","observed_orcids":["https://orcid.org/0000-0001-7178-8163"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maksim Mamonkin","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058287032","display_name":"Malcolm K. Brenner","orcid":"https://orcid.org/0000-0002-3657-7675","observed_orcids":["https://orcid.org/0000-0002-3657-7675"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malcolm K. Brenner","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081218567","display_name":"Erden Atilla","orcid":"https://orcid.org/0000-0002-8613-2105","observed_orcids":["https://orcid.org/0000-0002-8613-2105"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erden Atilla","raw_affiliation_strings":["Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1618,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.50045469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"22","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cd123","display_name":"CD123","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cd33","display_name":"CD33","score":1.0},{"id":"https://openalex.org/keywords/cll-1","display_name":"CLL-1","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cotransduction","display_name":"cotransduction","score":0.7739999890327454},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.6679999828338623},{"id":"https://openalex.org/keywords/antigenic-diversity","display_name":"antigenic diversity","score":0.593999981880188},{"id":"https://openalex.org/keywords/car-t-cell-expansion","display_name":"CAR-T cell expansion","score":0.6460000276565552},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.6091459393501282},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6069769859313965},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.591951310634613},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5687023997306824},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5602777600288391},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5175732374191284},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.49133744835853577},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4751857817173004},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.440470427274704},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4065529406070709},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3693264126777649},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.36045897006988525},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.27666935324668884},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.21091735363006592},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.13993757963180542},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.13948655128479004}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-141540","doi":"https://doi.org/10.1182/blood-2020-141540","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141540","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7200000286102295}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4318616170","https://openalex.org/W4283333352","https://openalex.org/W2077057971","https://openalex.org/W2892125791","https://openalex.org/W2076991609","https://openalex.org/W3012325124","https://openalex.org/W2566858610","https://openalex.org/W4310126652","https://openalex.org/W4309845615","https://openalex.org/W2412656109"],"abstract_inverted_index":{"Introduction:":[0],"Efforts":[1],"to":[2,40,244,280,332,339,445,461],"safely":[3],"and":[4,50,65,98,120,126,132,165,200,211,363,368,372,384,392,399,421,438,485,492],"effectively":[5],"treat":[6],"acute":[7],"myeloid":[8,59],"leukemia":[9,15],"(AML)":[10],"by":[11,123,129,189,266,357],"targeting":[12,67,381,412,494],"a":[13,71,92],"single":[14,204,333,491],"associated":[16,44,326,351,428],"antigen":[17,20,37,315,449,476],"with":[18,55,91,95,183,202,239,274,277,327,352,369,382,416,429],"chimeric":[19,36],"receptor":[21],"T":[22,82,281,335,365,387,414,425],"(CAR":[23],"T)":[24],"cells":[25,83,282,336,388,415,455],"have":[26],"had":[27,219],"limited":[28],"success.":[29],"We":[30,62,76,114,193,478],"determined":[31],"whether":[32],"combinatorial":[33,380],"expression":[34,57,201,224,291,324,467],"of":[35,58,81,146,197,225,249,289,303,404,413,432,487,513,525,536,548,568,581,598,610,621,633,653,675,693,707,718],"receptors":[38],"directed":[39],"two":[41],"different":[42],"AML":[43,112,137],"antigens":[45,149,308,407],"would":[46],"augment":[47],"tumor":[48,342,390,439],"eradication":[49],"prevent":[51],"relapse":[52],"in":[53,89,105,130,133,174,271,319,349,360,395,451,457,465,490,505,560,590,645,667,685],"targets":[54],"heterogeneous":[56],"antigens.":[60],"Methods:":[61],"generated":[63],"CD123":[64,152,159,167,278],"CD33":[66,154,161,169,275,417],"CARs;":[68],"each":[69,85],"containing":[70,232],"4-1BBz":[72],"or":[73,88,143,215,276,305,418,515,527,538,550,570,583,600,612,623,635,655,677,695,709,720],"CD28z":[74,96],"endodomain.":[75],"analyzed":[77,115],"the":[78,147,250,296,405,452,482],"anti-tumor":[79,264],"activity":[80,135,188,265],"expressing":[84,140,269,283,401],"CAR":[86,94,223,251,267,285,334,386,424,466,473],"alone":[87],"co-transduction":[90],"CLL-1":[93,156,163,171,209,270,284,385],"endodomain":[97],"CD8":[99,364],"hinge":[100],"previously":[101],"optimized":[102],"for":[103,111,496],"use":[104],"our":[106],"open":[107],"CAR-T":[108,116,354],"cell":[109,117,138,298,366,426],"trial":[110],"(NCT04219163).":[113],"phenotype,":[118],"expansion":[119,238],"transduction":[121,213],"efficacy":[122],"flow":[124],"cytometry":[125],"assessed":[127],"function":[128,437],"vitro":[131],"vivo":[134,175],"against":[136],"lines":[139,396],"high,":[141,153,155],"intermediate":[142],"low":[144,164,301],"levels":[145,196,242,302,330,347,403],"target":[148,297,307,406],"(Molm":[150],"13=":[151],"intermediate,":[157,170],"KG1a=":[158],"low,":[160,162,168],"HL60=":[166],"intermediate/high)":[172],"For":[173],"studies":[176],"we":[177,260],"used":[178],"NOD.SCID":[179],"IL-2Rg-/-3/GM/SF":[180],"(NSGS)":[181],"mice":[182],"established":[184],"leukemia,":[185],"determining":[186],"antitumor":[187],"bioluminescence":[190],"imaging.":[191],"Results:":[192],"obtained":[194],"high":[195],"gene":[198],"transfer":[199],"both":[203,306,361],"(CD33.4-1BB\u0293,":[205],"CD123.4-1BB\u0293,":[206],"CD33.CD28\u0293,":[207],"CD123.CD28\u0293,":[208],"CAR)":[210],"double":[212],"CD33/CD123.4-1BB\u0293":[214],"CD33/CD123.CD28\u0293)":[216],"although":[217],"single-transductants":[218],"marginally":[220],"higher":[221,328],"total":[222],"70%-80%":[226],"versus":[227],"60-70%":[228],"after":[229,448,475],"co-transduction.":[230],"Constructs":[231],"CD28":[233],"co-stimulatory":[234],"domain":[235,247],"exhibited":[236],"rapid":[237],"elevated":[240],"peak":[241],"compared":[243,279,331],"41BB":[245],"co-stim":[246],"irrespective":[248],"specificity.":[252],"(p<0.001)":[253],"(Fig":[254,311,343,408],"1a).":[255],"In":[256,378],"72h":[257],"co-culture":[258],"assays,":[259],"found":[261],"consistently":[262],"improved":[263,389],"Ts":[268],"combination":[272],"either":[273],"alone.":[286],"The":[287,441],"benefit":[288],"dual":[290,323,453,493],"was":[292,317,325],"most":[293],"evident":[294],"when":[295],"line":[299],"expressed":[300],"one":[304],"(e.g.":[309],"KG1a)":[310],"1b)":[312],"(P<0.001).":[313],"No":[314],"escape":[316],"detected":[318],"residual":[320],"tumor.":[321],"Mechanistically,":[322],"pCD3\u0293":[329,346,447],"on":[337,509,521,532,544,564,577,594,606,617,629,649,671,689,703,714],"exposure":[338],"any":[340],"given":[341],"1c).":[344],"Increased":[345],"were":[348],"turn":[350],"augmented":[353],"degranulation":[355],"(assessed":[356],"CD107a":[358],"expression)":[359],"CD4":[362],"populations":[367],"increased":[370,446],"TNF\u03b1":[371],"IFN\u0263":[373],"production":[374],"(p<0.001":[375],"Fig":[376],"1d).":[377],"vivo,":[379],"CD123/CD33.CD28\u0293":[383],"control":[391],"animal":[393],"survival":[394],"(KG1a,":[397],"MOLM13":[398],"HL60)":[400],"diverse":[402],"2).":[409],"Conclusion:":[410],"Combinatorial":[411],"CD123.CD28z":[419],"CARs":[420,495],"CLL-1-CAR":[422],"improves":[423],"activation":[427],"superior":[430,472],"recruitment/phosphorylation":[431],"CD3\u0293,":[433],"producing":[434],"enhanced":[435],"effector":[436],"control.":[440],"events":[442],"that":[443],"lead":[444],"engagement":[450],"transduced":[454],"may":[456,469],"part":[458],"be":[459],"due":[460],"an":[462,510,522,533,545,565,578,595,607,618,630,650,672,690,704,715],"overall":[463],"increase":[464],"but":[468],"also":[470],"reflect":[471],"recruitment":[474],"engagement.":[477],"are":[479],"now":[480],"comparing":[481],"formation,":[483],"structure,":[484],"stability":[486],"immune":[488],"synapses":[489],"AML.":[497],"Disclosures":[498],"Brenner:":[499],"Walking":[500,680],"Fish:":[501,681],"Current":[502,557,587,642,664,682],"equity":[503,558,588,643,665,683],"holder":[504,559,589,644,666,684],"publicly-traded":[506,591,646,668,686],"company,":[507,562,592,647,669,687],"Membership":[508,520,531,543,563,576,593,605,616,628,648,670,688,702,713],"entity's":[511,523,534,546,566,579,596,608,619,631,651,673,691,705,716],"Board":[512,524,535,547,567,580,597,609,620,632,652,674,692,706,717],"Directors":[514,526,537,549,569,582,599,611,622,634,654,676,694,708,719],"advisory":[516,528,539,551,571,584,601,613,624,636,656,678,696,710,721],"committees;":[517,529,540,585,614,625,679,711],"Bluebird":[518],"Bio:":[519,604],"Tumstone:":[530,615],"Tessa":[541,626],"Therapeutics:":[542,556,627],"committees,":[552,572,637,657,697],"Other:":[553,573,638,658],"Founder;":[554,574],"Maker":[555],"private":[561],"Memmgen:":[575],"Allogene:":[586,663],"committees.":[602,722],"Atilla:Bluebird":[603],"founder;":[639],"Marker":[640],"Therapeuticsa:":[641],"Founder,":[659],"Patents":[660,698],"&":[661,699],"Royalties;":[662,700],"Memgen:":[701],"KUUR:":[712]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}